Financial Summary (All financials)
| In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 2,184.5 | 1,294.4 | 406.2 | 310.7 |
| Revenue growth | 68.8% | 218.6% | 30.7% | |
| Cost of goods sold | 878.2 | 495.7 | 173.5 | 105.0 |
| Gross profit | 1,306.3 | 798.7 | 232.8 | 205.7 |
| Gross margin | 59.8% | 61.7% | 57.3% | 66.2% |
| Sales and marketing | 1,412.9 | 1,097.9 | 583.8 | 303.5 |
| Research and development | 800.2 | 614.8 | 491.3 | 398.6 |
| General and administrative | 445.4 | 420.1 | 157.8 | 203.1 |
| EBIT | -1,473.5 | -1,334.1 | -1,000.1 | -699.5 |
| EBIT margin | -67.5% | -103.1% | -246.2% | -225.1% |
| Pre-tax income | -1,441.9 | -1,339.9 | -963.8 | -656.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -1,441.9 | -4,177.9 | -1,564.3 | -900.4 |
| Net margin | -66.0% | -322.8% | -385.1% | -289.8% |
| |
| Diluted EPS | ($2.92) | ($44.68) | ($27.25) | ($18.50) |
| Shares outstanding (diluted) | 494.1 | 93.5 | 57.4 | 48.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|